Induced pluripotent stem (iPS) cells from human fetal stem cells

Article English OPEN
Guillot, P. V. (2016)
  • Publisher: ELSEVIER SCI LTD
  • Subject: Reprogramming, small molecules, fetal stem cells, induced pluripotency, transcription factors, translational medicine, Mesenchymal Stromal Cells, Small-molecule Compounds, OCT4 Promoter Activity, Valproic Acid, Somatic-cells, Osteogenesis Imperfecta, Human Fibroblasts, Nuclear Transfer, Defined Factors, High-efficiency

Pluripotency defines the ability of stem cells to differentiate into all the lineages of the three germ layers and self-renew indefinitely. Somatic cells can regain the developmental potential of embryonic stem cells following ectopic expression of a set of transcription factors or, in certain circumstances, via modulation of culture conditions and supplementation with small molecule, that is, induced pluripotent stem (iPS) cells. Here, we discuss the use of fetal tissues for reprogramming, focusing in particular on stem cells derived from human amniotic fluid, and the development of chemical reprogramming. We next address the advantages and disadvantages of deriving pluripotent cells from fetal tissues and the potential clinical applications.
  • References (70)
    70 references, page 1 of 7

    1. * Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, et al. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Molecular Therapy. 2012;doi: 10.1038/mt.2012.117.

    2. * Moschidou D, Guillot PV. Reprogramming human amniotic fluid stem cells to functional pluripotency by manipulation of culture conditions. Nature protocol exchange. 2012;doi:10.1038/protex.2012.032.

    3. * Moschidou D, Mukherjee S, Blundell MP, Jones GN, Atala AJ, Thrasher A, et al. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics. Stem Cells Dev. 2013;22(3):444-58.

    4. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-76.

    5. Yu J, Vodyanik MA, Smugga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-20.

    6. Takahashi K, Tanabe K, Ohnuki M, narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007 131(5):861-72.

    7. Nakagawa M, Tanigushi Y, Senda S, Takizawa N, Ichisaka T, Asano K, et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep. 2014;4:3594.

    8. Downing TL, Soto J, Morez C, Houssin T, Fritz A, Yuan F, et al. Biophysical regulation of epigenetic state and cell reprogramming. Nature Materials. 2013;12(12):1154-62.

    9. Li W, Ding S. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci. 2010;31(1):36-45.

    10. Rybouchkin A, Kato Y, Tsunoda Y. Role of histone acetylation in reprogramming of somatic nuclei following nuclear transfer. Biol Reprod. 2006;74(6):1083.

  • Related Research Results (1)
  • Metrics
    views in OpenAIRE
    views in local repository
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    UCL Discovery - IRUS-UK 0 33
Share - Bookmark

  • Download from
  • Cite this publication